Xtl Biopharmaceuticals (XTLB) Non-Current Debt (2017)
Xtl Biopharmaceuticals (XTLB) posted Non-Current Debt of $2.67 million for the quarter ended Dec 31, 2017.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Non-Current Debt (2017) Analysis & Trends
- The figure for the quarter ended Dec 31, 2017 stands as the highest quarterly Non-Current Debt since the quarter ended Dec 31, 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Xtl Biopharmaceuticals | 16.76 Mn | 13.56 Mn | - | - |
API Access
Xtl Biopharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();